E-Prescribing Standards Should Limit PBM Role, Pfizer Tells HHS Cmte.
Executive Summary
Pharmacy benefit management companies should not be permitted to control the clinical information delivered via electronic prescribing technology, Pfizer Business Technology Senior Manager Ross Martin told an HHS committee May 27
You may also be interested in...
Pfizer Weighs In On E-Prescribing: Pricing Granularity Critical
The level of drug pricing granularity available to health care providers via electronic prescribing systems is one key issue to be resolved in setting standards for e-prescribing under Medicare
E-Prescribing Voluntary Under Medicare Bill; HHS Will Develop Standards
Electronic prescribing programs are voluntary under the Medicare prescription drug conference bill, but must meet federal standards to be developed by HHS
FDA Has No Timeline For PBM Promotion Guidance Reissue
FDA does not have a timeline for reissuance of its draft guidance on promotions by pharmacy benefit management companies.